NRIX · Nurix Therapeutics, Inc.

$26.87 +0.16 (+0.58%) At close · Aug 27

Market Cap

$2.78B

103.78M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-07-09	2026-05-31
8-K	2026-07-09	—
8-K	2026-06-11	—
8-K	2026-06-08	2026-06-06
Investor Event Transcript	2026-06-03	2026-05-31
8-K	2026-05-15	—
Investor Event Transcript	2026-04-13	2026-05-31
8-K	2026-04-08	—
10-Q	2026-04-08	2026-02-28
DEF 14A	2026-03-27	2026-05-15
8-K	2026-03-06	—
10-K	2026-01-28	2025-11-30
8-K	2026-01-28	—
8-K	2026-01-12	—
8-K	2025-12-09	2025-12-06
8-K	2025-11-10	2025-11-06
8-K	2025-10-22	—
8-K	2025-10-22	—
8-K	2025-10-09	—
10-Q	2025-10-09	2025-08-31
8-K	2025-09-03	—
8-K	2025-08-22	2025-08-19
8-K	2025-07-09	—
10-Q	2025-07-09	2025-05-31
8-K	2025-06-12	—
8-K	2025-05-19	—
10-Q	2025-04-08	2025-02-28
8-K	2025-04-08	—
DEF 14A	2025-03-28	2025-05-19
8-K	2025-03-13	2025-03-11
10-K	2025-01-28	2024-11-30
8-K	2025-01-28	—
8-K	2025-01-13	—
8-K	2024-12-10	2024-12-09
8-K	2024-10-31	—
8-K	2024-10-16	2024-10-15
8-K	2024-10-11	—
10-Q	2024-10-11	2024-08-31
8-K	2024-09-05	—
10-Q	2024-07-11	2024-05-31
8-K	2024-07-11	—
8-K	2024-06-17	2024-06-16
8-K	2024-05-21	2024-05-20
8-K	2024-04-12	2024-04-11
10-Q	2024-04-10	2024-02-29
8-K	2024-04-10	—
8-K	2024-04-09	—
DEF 14A	2024-03-27	2024-05-20
8-K	2024-03-11	—
10-K	2024-02-15	2023-11-30

Showing 1–50 of 110 filings

Key facts CIK 1549595 CUSIP 67080M103 13F (30d) 193 filings 187 filers Visit website Investor relations